Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment

被引：85

作者：

Mazzaferro, V

Tagger, A

Schiavo, M

Regalia, E

Pulvirenti, A

Ribero, ML

Coppa, J

Romito, R

Burgoa, L

Zucchini, N

Urbanek, T

Bonino, F

机构：

[1] Natl Canc Inst, Dept Surg, Gastrointestinal Surg & Liver Transplantat Unit, Pathol Unit, I-20133 Milan, Italy

[2] Univ Milan, Inst Virol, Milan, Italy

[3] S Chiara United Hosp, Div Gastroenterol, Pisa, Italy

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02508-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1355 / 1357

页数：3

共 12 条

[1] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].

Bizollon, T ;

Palazzo, U ;

Ducerf, C ;

Chevallier, M ;

Elliott, M ;

Baulieux, J ;

Pouyet, M ;

Trepo, C .

HEPATOLOGY, 1997, 26 (02) :500-504

[2] Long-term outcome of hepatitis C infection after liver transplantation [J].

Cane, EJ ;

Portmann, BC ;

Naoumov, NV ;

Smith, HM ;

Underhill, JA ;

Donaldson, PT ;

Maertens, G ;

Williams, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :815-820

[3] Liver transplantation for chronic viral hepatitis [J].

Dodson, SF ;

Issa, S ;

Bonham, A .

SURGICAL CLINICS OF NORTH AMERICA, 1999, 79 (01) :131-+

[4] AN OPEN TRIAL OF INTERFERON-ALFA RECOMBINANT FOR HEPATITIS-C AFTER LIVER-TRANSPLANTATION - ANTIVIRAL EFFECTS AND RISK OF REJECTION [J].

FERAY, C ;

SAMUEL, D ;

GIGOU, M ;

PARADIS, V ;

DAVID, MF ;

LEMONNIER, C ;

REYNES, M ;

BISMUTH, H .

HEPATOLOGY, 1995, 22 (04) :1084-1089

[5] A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation [J].

Gane, EJ ;

Lo, SK ;

Riordan, SM ;

Portmann, BC ;

Lau, JYN ;

Naoumov, NV ;

Williams, R .

HEPATOLOGY, 1998, 27 (05) :1403-1407

[6] HISTOLOGICAL GRADING AND STAGING OF CHRONIC HEPATITIS [J].

ISHAK, K ;

BAPTISTA, A ;

BIANCHI, L ;

CALLEA, F ;

DEGROOTE, J ;

GUDAT, F ;

DENK, H ;

DESMET, V ;

KORB, G ;

MACSWEEN, RNM ;

PHILLIPS, MJ ;

PORTMANN, BG ;

POULSEN, H ;

SCHEUER, PJ ;

SCHMID, M ;

THALER, H .

JOURNAL OF HEPATOLOGY, 1995, 22 (06) :696-699

[7]

MAZZAFERRO V, 1995, HEPATOLOGY, V22, P722

[8] Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis [J].

Mazzaferro, V ;

Regalia, E ;

Doci, R ;

Andreola, S ;

Pulvirenti, A ;

Bozzetti, F ;

Montalto, F ;

Ammatuna, M ;

Morabito, A ;

Gennari, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :693-699

[9] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].

McHutchison, JG ;

Gordon, SC ;

Schiff, ER ;

Shiffman, ML ;

Lee, WM ;

Rustgi, VK ;

Goodman, ZD ;

Ling, MH ;

Cort, S ;

Albrecht, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492

[10] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].

Poynard, T ;

Marcellin, P ;

Lee, SS ;

Niederau, C ;

Minuk, GS ;

Ideo, G ;

Bain, V ;

Heathcote, J ;

Zeuzem, S ;

Trepo, C ;

Albrecht, J .

LANCET, 1998, 352 (9138) :1426-1432

← 1 2 →